Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Test, Medical Supply Manufacturers Working With Federal Agencies To Deter Second COVID-19 Wave

Hastened reopenings of businesses could lead to second outbreak by fall, health officials warn Congress

Executive Summary

To better control a possible secondary wave of coronavirus cases over the summer as some state governors reopen their economies for businesses, US federal agencies are working with test and medical supply manufacturers to expand capacity, officials told Congress.

You may also be interested in...



US Senators Question Leading Labs’ Capacity To Process Enough COVID-19 Tests To Slow Pandemic

Two Senate Democrats sent letters to five well-known US testing laboratories, questioning their ability to process sufficient COVID-19 tests.

Hahn: Expect More Telemedicine Promos, Public Service Messages On COVID-19 Protection From FDA

US FDA commissioner Stephen Hahn emphasized the important role that telemedicine, COVID-19 testing, and agency-reviewed face masks and ventilators have played during the pandemic in a 1 June speech.

Plan To ‘Reopen’ America Gradually Allows Return Of Elective Orthopedic, Colon, Eye Surgeries

Under guidelines recently unveiled by President Trump, US health care facilities could gradually start phasing-in more elective surgeries, including commonly performed operations that were postponed due the COVID-19 outbreak – many of which involve extensive device use. Elective surgeries include orthopedic joint replacement procedures, colonoscopies and cataract-correcting procedures that could resume as early as May under Trump’s plan.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT126740

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel